Company News »
Baxter to Present at the 2014 Credit Suisse Healthcare Conference
Baxter International Inc. (NYSE:BAX) announced today that it will present at the 2014 Credit Suisse Healthcare Conference on Wednesday, November 12, 2014 at 10:00 a.m. (CT).
The live webcast of Baxter’s presentation and accompanying slides can be accessed from the Baxter corporate website at www.baxter.com .
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
- Sterling Bounces After Solid Production and Retail Data 16 views
- Exact Sciences Reports Strong Growth Trajectory for CologuardTM in First-Quarter 2015 3 views
- US Productivity Falls 2 views
- USD/CAD Tests Support as Negative Momentum Accelerates 2 views
- Tesla Races Downward on Guidance 2 views
- Health Canada Issues Notice of Compliance for Gilead’s HarvoniTM (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C 2 views
- What’s the Story With the Sears Holdings-Simon Properties Deal? 2 views
- Western Union Offers Apple PayTM as New Pay-In Option for Money Transfer Customers 2 views
- Guidance Software Awarded 5-Star Rating in CRN’s 2015 Partner Program Guide 2 views
- Aussie rebounds from nearly 4-year low as US dollar drops 1 view
| Forex Broker Spreads » |
|
Iron FX
XM Markets
FxPro
FXCM| Most Popular Articles » |
- Sterling Bounces After Solid Production and Retail Data 16 views
- Exact Sciences Reports Strong Growth Trajectory for CologuardTM in First-Quarter 2015 3 views
- Western Union Offers Apple PayTM as New Pay-In Option for Money Transfer Customers 2 views
- Guidance Software Awarded 5-Star Rating in CRN’s 2015 Partner Program Guide 2 views
- US Productivity Falls 2 views
- USD/CAD Tests Support as Negative Momentum Accelerates 2 views
- Tesla Races Downward on Guidance 2 views
- Health Canada Issues Notice of Compliance for Gilead’s HarvoniTM (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C 2 views
- What’s the Story With the Sears Holdings-Simon Properties Deal? 2 views
- European Session – Dollar under 120.00 yen ahead of FOMC minutes 1 view